Daiichi Sankyo Company, Limited DSKYF · OTC
$16.55 -3.79% (-$0.65)
Summary
69 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 65% a year over the last 3 years.
- It holds more cash than debt: ¥633.2B against ¥496.9B.
- Out of every 100 JPY of revenue, 11 JPY is left as net profit.
- It bought back its own shares for ¥246.1B in the last fiscal year, 5.1% of its market value.
What to watch
- The share price is above the Bulios Fair Price.
- It reports a profit, yet spends more cash than it brings in.
- It earns only 5.8 JPY a year on every 100 JPY of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 19.6 JPY for 1 JPY of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (JPY)
Diluted EPS (JPY)
- Analyst estimate
Revenue grew by 14% a year over 5 years. Over the last 3 years it grew by 22% a year. For the next fiscal year analysts expect revenue to grow by 14%. Earnings per share grew by 65% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 JPY of revenue goes
- Cost of sales 32 JPY
- Research and development 21 JPY
- Sales and administration 38 JPY
- Taxes and other -2.1 JPY
- Net profit 11 JPY
Net profit, industry median (Drug Manufacturers - General) 14 JPY
Out of every 100 JPY of revenue, 11 JPY is left as net profit.
Profitability in detailIs it financially healthy?
YesOver the last 12 months it spent more cash than it brought in. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
Moderate, at risk- Yield
- 3.36%
- Paid out of profit
- 66%
- Raised in a row
- 3 years
You receive $0.56 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.